8,517 articles
Mario Cazzola
Mario Cazzola, born in 1947, is an Italian hematologist who was Professor of Hematology at the University of Pavia from 2001 to 2017 and created the WPSS prognostic system for myelodysplastic syndromes.
Mario Clerici
Mario Clerici is an Italian immunologist, full professor at the University of Milan and Scientific Director of the Fondazione Don Carlo Gnocchi IRCCS, known for HIV resistance research.
Mario Gaudino
Mario Gaudino is an Italian cardiac surgeon and clinical trialist at Weill Cornell Medicine in New York, known for the 2018 radial artery bypass study and the ROMA trials.
Mario L. Suvà
Mario L. Suvà is a physician-scientist, Vice-Chair of Pathology for Research at Massachusetts General Hospital and Harvard associate professor, known for single-cell studies of glioma cellular states.
Mario Raviǵlione
Mario Raviǵlione, also known as Mario C. Raviglione, is an Italian physician who directed the WHO Global Tuberculosis Programme from 2003 to 2017, developing the End TB Strategy.
Mario Rizzetto
Mario Rizzetto (born 1945) is an Italian hepatologist who discovered the delta antigen of the hepatitis D virus in 1977 and won the 1985 King Faisal Prize.
Mario Sims
Mario Sims is an American social epidemiologist and medical sociologist, a distinguished professor at UC Riverside elected to the National Academy of Medicine in 2022.
Mario Spagnuolo
Mario Spagnuolo was an American public health researcher at New York University's School of Medicine and Irvington House, known for his 1971 study of rheumatic fever recurrence after streptococcal infections.
Marion Campbell
Marion K. Campbell is a British medical statistician and clinical trialist, Professor of Health Services Research at the University of Aberdeen, known for surgical trial design.
Marion Koopmans
Marion Koopmans is a Dutch public health virologist at Erasmus MC in Rotterdam, known for her work on noroviruses, avian influenza outbreaks, and SARS-CoV-2 surveillance and origins research.
Marissa Zwald
Marissa L. Zwald is an American epidemiologist at the CDC whose research tracks mental health, substance use, suicide, and firearm-injury trends using near-real-time emergency care data.
Marius M. Hoeper
Marius M. Hoeper is a German pulmonologist, director of respiratory medicine at Hannover Medical School, who helped develop most drugs approved for pulmonary arterial hypertension.
Mark A. Creager
Mark A. Creager is an American cardiologist and vascular medicine researcher at Dartmouth's Geisel School of Medicine who served as President of the American Heart Association.
Mark A. Hlatky
Mark A. Hlatky is an American cardiologist and emeritus Stanford professor of health policy and medicine, known for the 2009 Lancet analysis of bypass surgery versus angioplasty.
Mark A. Klebanoff
Mark A. Klebanoff, known as Mark Klebanoff, is an American pediatrician and perinatal epidemiologist at Nationwide Children's Hospital and Ohio State known for trials of bacterial vaginosis treatment to prevent preterm birth.
Mark A. Mintun
Mark A. Mintun is an American nuclear medicine physician-scientist who produced the first in vivo PET visualization of brain neuroreceptors and led development of donanemab.
Mark A. Rubin
Mark A. Rubin is an American pathologist and prostate cancer genomics researcher who helped define the molecular landscape of prostate cancer and leads precision medicine at the University of Bern.
Mark A. Socinski
Mark A. Socinski is an American medical oncologist specializing in lung cancer and mesothelioma, and Executive Medical Director of the AdventHealth Cancer Institute in Orlando, Florida.
Mark A. Sussman
Mark A. Sussman is an American cardiovascular molecular biologist, Distinguished Professor of Biology at San Diego State University, known for research on cardiomyocyte survival and cardiac regeneration.
Mark A. Wainberg
Mark A. Wainberg (1945–2017) was a Canadian virologist at McGill University and the first in Canada to work directly on HIV, best known for identifying the antiretroviral drug 3TC (lamivudine) in 1989.
Mark Abie Horowitz
Mark Abie Horowitz is an Australian-trained psychiatrist and researcher at University College London, co-author of the 2022 review that found no support for the serotonin theory of depression.
Mark B. Faries
Mark B. Faries is an American surgical oncologist and melanoma specialist who leads Surgical Oncology at The Angeles Clinic in Los Angeles and led the MSLT-II trial.
Mark B. Feinberg
Mark B. Feinberg is an American physician-scientist who has led the International AIDS Vaccine Initiative as president and CEO since 2015, after 11 years at Merck Vaccines.
Mark Bothwell
Mark Bothwell is a neuroscientist and professor of neurobiology at the University of Washington known for work on neurotrophins, the growth factors that control neuron survival.
Mark Bower
Mark Bower is a British medical oncologist, Professor at Imperial College London and consultant at Chelsea and Westminster Hospital, known for AIDS-related cancer care and a 2006 Kaposi's sarcoma prognostic index.
Mark C. Genovese
Mark C. Genovese is an American rheumatologist who spent over two decades at Stanford leading phase 3 trials of rheumatoid arthritis drugs, then joined Gilead Sciences in 2020.
Mark C. Petrie
Mark C. Petrie is a Scottish cardiologist and Professor of Cardiology at the University of Glasgow, known for heart failure research and the STEP-HFpEF semaglutide trial.
Mark C. Steinhoff
Mark C. Steinhoff was an American physician-scientist at Johns Hopkins and Cincinnati Children's whose trials showed flu vaccination during pregnancy protects both mother and newborn.
Mark Crowther
Mark A. Crowther is a Canadian hematologist and thrombosis physician-scientist at McMaster University in Hamilton, Ontario, known for clinical trials of anticoagulant reversal agents, including andexanet alfa.
Mark D. Altschule
Mark D. Altschule was a physician-investigator at Harvard Medical School, McLean Hospital, and Beth Israel Hospital whose 1956 progesterone trial anticipated modern neurosteroid treatment of postpartum depression.